Cushing's syndrome due to surreptitious inhalation of fluticasone propionate

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 1, 1999, Pages 94-95

  Burger, A L ^a   Stanton, S F ^a   Wilson, J D ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; PREDNISONE;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DRUG OVERDOSE; EDEMA; FEMALE; HIRSUTISM; HUMAN; WEIGHT GAIN;

EID: 0033048822     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb01600.x     Document Type: Article

References (4)

1. 1. Cizza G, Nieman LK, Doppman LJ et al. Factitious Cushing syndrome. J Clin Endocrinol Metab 1996; 81: 3573-7.
2. 2. Chalkey SM, Chisholm DJ. Cushing's syndrome from inhaled glucocorticoid. Med J Aust 1994; 160: 611-15.
3. 3. Thorsson L, Dahlstrom K, Edsbacker S, Kallen A, Paulson J, Wiren JE. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997; 43: 155-61.
4. 4. Fabbi L, Burge PS, Groonenborgh L et al. Comparison of fluticasone propionate with beclomethasone diproprionate in moderate to severe asthma treated for one year. Thorax 1993; 48: 817-23.